Polysubstance Use Profiles Among the General Adult Population, United States, 2022.
Objectives. To characterize present-day polysubstance use patterns in the general adult population. Methods. From a 2022 nationally representative survey in the United States, we defined polysubstance use as last 12-month use of 2 or more drugs (n = 15 800). Latent class analyses included medical (a...
| Publicado en: | American Journal of Public Health Vol. 115; no. 5; pp. 747 - 758 |
|---|---|
| Autores principales: | , , , |
| Formato: | Artículo |
| Publicado: |
American Public Health Association
May2025
|
| Materias: | |
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=184341991&site=ehost-live header: @attributes: shortDbName: ssf uiTerm: 184341991 longDbName: Social Sciences Full Text (H.W. Wilson) uiTag: AN controlInfo: bkinfo: jinfo: jid: 00900036 APH jtl: American Journal of Public Health issn: 00900036 maglogo: N pubinfo: dt: May2025 vid: 115 iid: 5 pid: 44 pub: American Public Health Association artinfo: ui: 184341991 10.2105/AJPH.2024.307979 ppf: 747 ppct: 11 formats: tig: atl: Polysubstance Use Profiles Among the General Adult Population, United States, 2022. aug: au: Rockhill, Karilynn M. Black, Joshua C. Iwanicki, Janetta Abraham, Alison affil: Department of Epidemiology, University of Colorado Anschutz Medical Campus, Aurora, CO. Rocky Mountain Poison & Drug Safety, Denver Health & Hospital Authority, Denver, CO., Rocky Mountain Poison & Drug Safety, Denver Health & Hospital Authority, Denver, CO. su: United States Substance abuse risk factors Substance abuse Cross-sectional method Public health Psychiatric drugs Behavior therapy Adults Risk assessment Cannabis (Genus) sug: subj: Substance abuse risk factors Substance abuse Cross-sectional method Public health Psychiatric drugs Behavior therapy Adults United States Health and Welfare Funds Risk assessment Cannabis (Genus) ab: Objectives. To characterize present-day polysubstance use patterns in the general adult population. Methods. From a 2022 nationally representative survey in the United States, we defined polysubstance use as last 12-month use of 2 or more drugs (n = 15 800). Latent class analyses included medical (as indicated) and nonmedical (not as directed) use of prescription opioids, stimulants, benzodiazepines, and antidepressants; recreational use of cannabis, psilocybin or mushrooms, other psychedelics, cocaine, methamphetamine, and illicit opioids; and concomitant use with alcohol, cannabis, prescriptions, or recreational drugs. Results. The national prevalence of polysubstance use was 20.9% (95% confidence interval = 20.5%, 21.3%), broken down into the following 4 latent classes: (1) medically guided polysubstance use (11.5% prevalence, 6.1% substance use disorder [SUD]): prescribed drug use, some cannabis, and no concomitant use; (2) principal cannabis use variety (4.0% prevalence, 31.9% SUD): high probability of cannabis use with various drugs concomitantly used; (3) self-guided polysubstance use (3.4% prevalence, 14.5% SUD): nonmedical use of prescriptions and concomitant use; and (4) indiscriminate coexposures (2.1% prevalence, 58.9% SUD): concomitant drug use with indiscriminate drug preference. Conclusions. Different polysubstance profiles show adults with untreated SUDs, and there are 2 previously unrecognized classes. Prevention and treatment strategies addressing polysubstance use should take a personalized perspective and tailor to individuals' use profile. pubtype: Academic Journal doctype: Article src: R language: English refInfo: copyright: @attributes: flag: N holdings: @attributes: islocal: N |
|---|